Trial
NCT03247413
Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Neuritis
Intervention
Dexamethasone 4 mg/ml
Why stopped
Study has been halted prematurely
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-05